These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9054799)
1. Contractures in neuroleptic malignant syndrome. Craddock B; Craddock N Am J Psychiatry; 1997 Mar; 154(3):436. PubMed ID: 9054799 [No Abstract] [Full Text] [Related]
2. Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia. Black KJ; Racette B; Perlmutter JS Am J Psychiatry; 1998 Sep; 155(9):1298-9. PubMed ID: 9734560 [No Abstract] [Full Text] [Related]
3. [Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome]. Silva HC; Bahia VS; Oliveira RA; Marchiori PE; Scaff M; Tsanaclis AM Arq Neuropsiquiatr; 2000 Sep; 58(3A):713-9. PubMed ID: 10973114 [TBL] [Abstract][Full Text] [Related]
4. Treatment of neuroleptic malignant syndrome with electroconvulsive therapy. Lazarus A J Nerv Ment Dis; 1986 Jan; 174(1):47-9. PubMed ID: 3941310 [TBL] [Abstract][Full Text] [Related]
11. Catatonic and non-catatonic neuroleptic malignant syndrome. Lee JW Aust N Z J Psychiatry; 2000 Oct; 34(5):877-8. PubMed ID: 11037384 [No Abstract] [Full Text] [Related]
12. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?]. Weller M; Kornhuber J Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832 [TBL] [Abstract][Full Text] [Related]
14. The aftercare of the patient with the neuroleptic malignant syndrome. Aizenberg D; Shalev A; Munitz H Br J Psychiatry; 1985 Mar; 146():317-8. PubMed ID: 2985164 [TBL] [Abstract][Full Text] [Related]
15. A case of neuroleptic malignant syndrome with myoglobinuric acute renal failure treated with dialysis and levodopa. Lambrecht ER; Meems BJ Neth J Med; 1987 Feb; 30(1-2):80-4. PubMed ID: 3587463 [No Abstract] [Full Text] [Related]
16. Neuroleptic malignant syndrome. Review of response to therapy. Rosenberg MR; Green M Arch Intern Med; 1989 Sep; 149(9):1927-31. PubMed ID: 2673115 [TBL] [Abstract][Full Text] [Related]
17. Coexistence of neuroleptic malignant syndrome and a hyperosmolar hyperglycemic state. Yang CW; Lu C; Wu CC; Wen SC Am J Emerg Med; 2012 Jun; 30(5):833.e1-2. PubMed ID: 21514763 [TBL] [Abstract][Full Text] [Related]
18. Hyperosmolar hyperglycemic state secondary to neuroleptic malignant syndrome. Takanobu K; Okazaki D; Ogawa T; Watanabe S; Oka M; Murakami S; Ura H Am J Emerg Med; 2015 Jan; 33(1):126.e1-2. PubMed ID: 25151326 [TBL] [Abstract][Full Text] [Related]
19. Plasmapheresis in neuroleptic malignant syndrome. Gaitini L; Fradis M; Vaida S; Krimerman S; Beny A Anaesthesia; 1997 Feb; 52(2):165-8. PubMed ID: 9059103 [TBL] [Abstract][Full Text] [Related]
20. ECT during and after the neuroleptic malignant syndrome: case report. Hughes JR J Clin Psychiatry; 1986 Jan; 47(1):42-3. PubMed ID: 3941060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]